175 related articles for article (PubMed ID: 15191645)
21. Using computational techniques in fragment-based drug discovery.
Desjarlais RL
Methods Enzymol; 2011; 493():137-55. PubMed ID: 21371590
[TBL] [Abstract][Full Text] [Related]
22. Transcriptional-based screens for pathway-specific, high-throughput target discovery in endothelial cells.
Yauch RL; Kadel EE; Nicholas C; Tetangco S; Clary DO
J Biomol Screen; 2004 Dec; 9(8):704-11. PubMed ID: 15634797
[TBL] [Abstract][Full Text] [Related]
23. Virus-based expression systems facilitate rapid target in vivo functionality validation and high-throughput screening.
Darrow AL; Conway KA; Vaidya AH; Rosenthal D; Wildey MJ; Minor L; Itkin Z; Kong Y; Piesvaux J; Qi J; Mercken M; Andrade-Gordon P; Plata-Salamán C; Ilyin SE
J Biomol Screen; 2003 Feb; 8(1):65-71. PubMed ID: 12854999
[TBL] [Abstract][Full Text] [Related]
24. Optimization procedure for small interfering RNA transfection in a 384-well format.
Borawski J; Lindeman A; Buxton F; Labow M; Gaither LA
J Biomol Screen; 2007 Jun; 12(4):546-59. PubMed ID: 17435168
[TBL] [Abstract][Full Text] [Related]
25. Learning from the data: mining of large high-throughput screening databases.
Yan SF; King FJ; He Y; Caldwell JS; Zhou Y
J Chem Inf Model; 2006; 46(6):2381-95. PubMed ID: 17125181
[TBL] [Abstract][Full Text] [Related]
26. Lipidic carriers of siRNA: differences in the formulation, cellular uptake, and delivery with plasmid DNA.
Spagnou S; Miller AD; Keller M
Biochemistry; 2004 Oct; 43(42):13348-56. PubMed ID: 15491141
[TBL] [Abstract][Full Text] [Related]
27. Construction and transfection of PCR products expressing siRNAs or shRNAs in mammalian cells.
Castanotto D; Rossi JJ
Methods Mol Biol; 2004; 252():509-14. PubMed ID: 15017076
[TBL] [Abstract][Full Text] [Related]
28. Recent progress in biomolecular engineering.
Ryu DD; Nam DH
Biotechnol Prog; 2000; 16(1):2-16. PubMed ID: 10662483
[TBL] [Abstract][Full Text] [Related]
29. On-chip screening method for cell migration genes based on a transfection microarray.
Onuki-Nagasaki R; Nagasaki A; Hakamada K; Uyeda TQ; Fujita S; Miyake M; Miyake J
Lab Chip; 2008 Sep; 8(9):1502-6. PubMed ID: 18818805
[TBL] [Abstract][Full Text] [Related]
30. siRNAs in drug discovery: target validation and beyond.
Natt F
Curr Opin Mol Ther; 2007 Jun; 9(3):242-7. PubMed ID: 17608022
[TBL] [Abstract][Full Text] [Related]
31. Functional genomics and proteomics in the clinical neurosciences: data mining and bioinformatics.
Phan JH; Quo CF; Wang MD
Prog Brain Res; 2006; 158():83-108. PubMed ID: 17027692
[TBL] [Abstract][Full Text] [Related]
32. Inhibitors of FabI, an enzyme drug target in the bacterial fatty acid biosynthesis pathway.
Lu H; Tonge PJ
Acc Chem Res; 2008 Jan; 41(1):11-20. PubMed ID: 18193820
[TBL] [Abstract][Full Text] [Related]
33. High-content screening moves to the front of the line.
Haney SA; LaPan P; Pan J; Zhang J
Drug Discov Today; 2006 Oct; 11(19-20):889-94. PubMed ID: 16997138
[TBL] [Abstract][Full Text] [Related]
34. Exploring the sounds of silence: RNAi-mediated gene silencing for target identification and validation.
Chatterjee-Kishore M; Miller CP
Drug Discov Today; 2005 Nov; 10(22):1559-65. PubMed ID: 16257379
[TBL] [Abstract][Full Text] [Related]
35. Statistical analysis of systematic errors in high-throughput screening.
Kevorkov D; Makarenkov V
J Biomol Screen; 2005 Sep; 10(6):557-67. PubMed ID: 16103415
[TBL] [Abstract][Full Text] [Related]
36. RNAi microarray analysis in cultured mammalian cells.
Mousses S; Caplen NJ; Cornelison R; Weaver D; Basik M; Hautaniemi S; Elkahloun AG; Lotufo RA; Choudary A; Dougherty ER; Suh E; Kallioniemi O
Genome Res; 2003 Oct; 13(10):2341-7. PubMed ID: 14525932
[TBL] [Abstract][Full Text] [Related]
37. Statistical and graphical methods for quality control determination of high-throughput screening data.
Gunter B; Brideau C; Pikounis B; Liaw A
J Biomol Screen; 2003 Dec; 8(6):624-33. PubMed ID: 14711388
[TBL] [Abstract][Full Text] [Related]
38. Fabrication of cell-based arrays using micropatterned alkanethiol monolayers for the parallel silencing of specific genes by small interfering RNA.
Fujimoto H; Yoshizako S; Kato K; Iwata H
Bioconjug Chem; 2006; 17(6):1404-10. PubMed ID: 17105217
[TBL] [Abstract][Full Text] [Related]
39. Plate-based diversity selection based on empirical HTS data to enhance the number of hits and their chemical diversity.
Sukuru SC; Jenkins JL; Beckwith RE; Scheiber J; Bender A; Mikhailov D; Davies JW; Glick M
J Biomol Screen; 2009 Jul; 14(6):690-9. PubMed ID: 19531667
[TBL] [Abstract][Full Text] [Related]
40. How will RNAi facilitate drug development?
Bartz S; Jackson AL
Sci STKE; 2005 Aug; 2005(295):pe39. PubMed ID: 16077085
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
